Study: NCT05238922

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INCB0123667
Description: 25 mg tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INCB0123667
Description: 25 mg tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INCB0123667
Description: 25 mg tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INCB0123667
Description: 25 mg tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INCB0123667
Description: 25 mg tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INCB0123667
Description: 25 mg tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INCB0123667
Description: 25 mg tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INCB0123667
Description: 25 mg tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INCB0123667
Description: 25 mg tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INCB0123667
Description: 25 mg tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INCB0123667
Description: 25 mg tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INCB0123667
Description: 25 mg tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INCB0123667
Description: 25 mg tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INCB0123667
Description: 25 mg tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INCB0123667
Description: 25 mg tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INCB0123667
Description: 25 mg tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INCB0123667
Description: 25 mg tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INCB0123667
Description: 25 mg tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INCB0123667
Description: 25 mg tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INCB0123667
Description: 25 mg tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INCB0123667
Description: 25 mg tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Palbociclib
Description: Palbociclib will be administered at protocol defined dose.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Palbociclib
Description: Palbociclib will be administered at protocol defined dose.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Palbociclib
Description: Palbociclib will be administered at protocol defined dose.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Palbociclib
Description: Palbociclib will be administered at protocol defined dose.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: Bevacizumab will be administered at protocol defined dose.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: Bevacizumab will be administered at protocol defined dose.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Olaparib
Description: Olaparib will be administered at protocol defined dose.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Olaparib
Description: Olaparib will be administered at protocol defined dose.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: Paclitaxel will be administered at protocol defined dose.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: Paclitaxel will be administered at protocol defined dose.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ribociclib
Description: Ribociclib will be administered at protocol defined dose.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ribociclib
Description: Ribociclib will be administered at protocol defined dose.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ribociclib
Description: Ribociclib will be administered at protocol defined dose.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ribociclib
Description: Ribociclib will be administered at protocol defined dose.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fulvestrant
Description: Fulvestrant will be administered at protocol defined dose.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fulvestrant
Description: Fulvestrant will be administered at protocol defined dose.